相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
Kelly L. Bolton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan Ledermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
Platinum Sensitivity-Related Germline Polymorphism Discovered via a Cell-Based Approach and Analysis of Its Association with Outcome in Ovarian Cancer Patients
R. Stephanie Huang et al.
CLINICAL CANCER RESEARCH (2011)
Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
Da Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Albert Lai et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
M. P. Coleman et al.
LANCET (2011)
Suppression of lung adenocarcinoma progression by Nkx2-1
Monte M. Winslow et al.
NATURE (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Unifying Gene Expression Measures from Multiple Platforms Using Factor Analysis
Xin Victoria Wang et al.
PLOS ONE (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
Martin Koebel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis
K. Levanon et al.
ONCOGENE (2010)
Gene Expression Profile for Predicting Survival in Advanced-Stage Serous Ovarian Cancer Across Two Independent Datasets
Kosuke Yoshihara et al.
PLOS ONE (2010)
Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
Dariush Etemadmoghadam et al.
CLINICAL CANCER RESEARCH (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A prognostic gene expression index in ovarian cancer - validation across different independent data sets
Carsten Denkert et al.
JOURNAL OF PATHOLOGY (2009)
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
Noriyuki Katsumata et al.
LANCET (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Survival in Advanced Ovarian Cancer and Gene Expression Signature
[Anonymous]
GINECO RO (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Survival-Related Profile, Pathways, and Transcription Factors in Ovarian Cancer
Anne P. G. Crijns et al.
PLOS MEDICINE (2009)
A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer
Tomas Bonome et al.
CANCER RESEARCH (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis
Chad J. Creighton et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
AffyProbeMiner: a web resource for computing or retrieving accurately redefined Affymetrix probe sets
Hongfang Liu et al.
BIOINFORMATICS (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
被撤回的出版物: An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer (Retracted article. See vol. 30, pg. 678, 2012)
Holly K. Dressman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Mismatch repair and treatment resistance in ovarian cancer
Jozien Helleman et al.
BMC CANCER (2006)
Notch3 gene amplification in ovarian cancer
Joon T. Park et al.
CANCER RESEARCH (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers
AA Jazaeri et al.
CLINICAL CANCER RESEARCH (2005)
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon
RT Marquez et al.
CLINICAL CANCER RESEARCH (2005)
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy
LC Hartmann et al.
CLINICAL CANCER RESEARCH (2005)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Gene expression signature with independent prognostic significance in epithelial ovarian cancer
D Spentzos et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients
G Gifford et al.
CLINICAL CANCER RESEARCH (2004)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
MC King et al.
SCIENCE (2003)
Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group trial
M Markman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
